Sign In
Get Clay Free →

Suggestions

    Helen Cai

    Director of Talent Acquisition at GSK

    Helen Cai is an experienced HR professional who has held leadership positions in talent acquisition and human resources at several major companies. She served as the Director of Talent Acquisition at GSK (GlaxoSmithKline) from August 2019 to March 2021, where she was responsible for talent acquisition in Greater China.2

    Prior to her role at GSK, Helen worked at Accenture Greater China in various HR leadership positions. She was the HR Director for Talent Acquisition Lead and HR Director for Consulting Workforce.1 Her experience at Accenture included implementing projects in resource forecasting and planning, M&A, sales leadership development, employer branding, and talent acquisition transformation.1

    Helen's career in HR spans over 20 years, during which she has gained extensive talent management experience in Greater China.1 She has also held positions at other multinational companies, including:

    • Texas Instruments (TI)
    • Siemens
    • 163.com (a Chinese internet company)1

    In her various roles, Helen has demonstrated expertise in:

    • Strategic workforce planning
    • Organization change and development
    • Talent attraction and development
    • Leadership development
    • M&A management1

    Helen's experience and skills have made her a valuable asset in the field of talent acquisition and HR management, particularly in the Greater China region.

    Highlights

    May 24 · businesswire.com
    Helen Cai Joins Largo's Board of Directors - Business Wire
    Speakers Next Practices in HR | AmCham Shanghai on Glue Up

    Related Questions

    What are Helen Cai's key achievements in Talent Acquisition at GSK?
    How has Helen Cai's career evolved over the past two decades?
    What specific projects has Helen Cai led in Greater China at GSK?
    What are Helen Cai's main responsibilities as Head of Talent Acquisition for Greater China at GSK?
    How has Helen Cai's experience at Accenture influenced her role at GSK?